IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
35 hedge funds and large institutions have $99.6M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
35
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$751K | |
| 2 | +$137K | |
| 3 | +$54.4K | |
| 4 |
Jane Street
New York
|
+$49.3K |
| 5 |
MP
McDonald Partners
Cleveland,
Ohio
|
+$43.9K |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$538K | |
| 3 | -$336K | |
| 4 |
Millennium Management
New York
|
-$155K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$131K |